Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Vanya Kostadinova"'
Publikováno v:
Journal of IMAB, Vol 26, Iss 3, Pp 3259-3266 (2020)
Purpose: To assess the efficacy of Azithromycin on exacerbations in patients with chronic obstructive pulmonary disease (COPD) and history of two or more flare-ups in the last 12 months and to study the influence of concomitant bronchiectasis on its
Externí odkaz:
https://doaj.org/article/5d43c672568948af822feed6816e5a61
Publikováno v:
British Journal of Medical and Health Research. 5:41-46
Publikováno v:
CBU International Conference Proceedings. 5:978-982
Introduction: Various biomarkers are used to evaluate the severity and prognosis of community acquired pneumonia (CAP).Objectives: To study and compare the prognostic value of MR-proADM, РСТ and CRP in predicting the severity and outcome of C
Publikováno v:
Clinical Problems.
Introduction: HRCT is helpful method for detecting emphysema in COPD. Aim: To evaluate emphysema prevalence on HRCT in a COPD cohort and its relation to some clinical and laboratory parameters. Methods: It was an observational study of 131 patients w
Publikováno v:
Airway Pharmacology and Treatment.
Introduction: Macrolides are used to reduce COPD exacerbatios and the loss of lung volume via reduction of local bronchial inflammation. Aim: To access the efficacy of azithromycin in patients with COPD and frequent exacerbations (≥2/year) and to e
Publikováno v:
10.1 Respiratory Infections.
Introduction: Bronchiectasis–COPD overlap syndrome(BCOS)was recently defined and need further investigations. Aim: To assess how bronchiectasis influence the course of COPD. Methods :HRCT were performedin 119 COPD patients followed up for one year(
Publikováno v:
10.1 Respiratory Infections.
Introduction: Different biomarkers are used to determine the severity and prognosis of community-acquired pneumonia (CAP) Aim: To evaluate the role of procalcitonin (PCT) in predicting the severity and risk of in-hospital mortality in patients with C
Publikováno v:
10.1 Respiratory Infections.
Introduction: Community-acquired pneumonia is a common disease with frequent hospitalization and still high mortality rate. The influence of comorbid illnesses on the course of pneumonia is often underestimated. Aim: To evaluate the impact of comorbi
Publikováno v:
5.2 Monitoring Airway Disease.
Introduction: Chronic bronchial infection in COPD patients is defined as presence of potential pathogenic microorganisms (PPMs) in their respiratory secrets. Aim: To assess the presence of pathogenic microorganisms in sputum of patients with stable C
Publikováno v:
Scripta Scientifica Medica. 49:58
Introduction: Various biomarkers are used to determine the severity and risk of mortality in community-acquired pneumonia (CAP). The aim of this article is to evaluate the prognostic value for in-hospital mortality of leukocyte count (Leuk), C-reacti